BioSpace News Archive

PharmaEssentia Corporation (TPEx: 6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today announced that the U.S. Food and Drug Administration (FDA) has recently accepted its Biol

Oragenics, Inc. (NYSE American: OGEN) , announced today that Alan Joslyn, Ph.D., President and CEO of Oragenics, Inc., will give a virtual corporate presentation at the June 2020 Virtual Summer Investor Summit taking place online from June 9th to 12th, 2020. The presentation will be held on Wednesday, June 10, 2020 at 2:10 pm ET, fo

Flywheel, a leading research data platform designed for the academic, clinical and life science communities, announced today its launch of Flywheel for Life Sciences.

Massachusetts Company Repurposes Capabilities to Package 3D-Printed Nasal Swabs For COVID-19 Testing and Seeks to Hire Additional Workers as Production Ramps Up

Jupiter Medical Center, the number one ranked hospital for safety, quality and patient satisfaction in Palm Beach County and the Treasure Coast region, today announced the appointment of Charles Murphy, Jr., MD, CPPS as Chief Quality and Patient Safety Officer.

The global Artificial Intelligence company Expert System announced today that the French National Institute of Health and Medical Research, Inserm, has decided to implement its Clinical Research Navigator (CRN) tool and make it available to 100 of its researchers for an evaluation period of six months.

ATC Alert LLC, a leading Connected Health company, today announced the completion of its acquisition of East Rock Medical Alert’s PERS accounts.

The Institute for Research in Immunology and Cancer of the Université de Montréal is proud to announce that David Knapp and Geneviève Deblois have been recruited as new Principal Investigators.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE) has appointed biotech

Weekly prizes aim to reduce migraine days for patients and culminate in a grand prize of the FDA-cleared medical device to mark National Migraine and Headache Awareness Month this June [04-June-2020] NEW YORK , June 4, 2020 /PRNewswire/ -- CEFALY , the first device of its kind to receive FDA medical clearance for migraine headaches, is launching a nationwide giveaway